Microbio Co (ROCO:4128) EBITDA: NT$-665 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4128 Microbio Co Ltd ROCO:4128
56 GF Score
Price NT$15.85
GF Value NT$45.77
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Microbio Co EBITDA?

Microbio Co ROCO:4128 -1.55% 56 EBITDA is NT$-665 Mil as of Dec. 2025. GuruFocus rates ROCO:4128 with a GF Score™ of 56/100 and a GF Value™ of NT$45.77 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Microbio Co's EBITDA for the three months ended in Dec. 2025 was NT$-32 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-665 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Microbio Co was 59.90% per year. The lowest was -78.40% per year. And the median was -25.80% per year.

Microbio Co's EBITDA per Share for the three months ended in Dec. 2025 was NT$-0.05. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-1.14.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Microbio Co was 36.60% per year. The lowest was -66.90% per year. And the median was -17.10% per year.

Microbio Co  (ROCO:4128) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Microbio Co EBITDA Related Terms


Microbio Co EBITDA Historical Data

* Premium members only.

The historical data trend for Microbio Co's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbio Co EBITDA Chart

Microbio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.56 400.41 -1,125.08 -1,001.67 -665.16

Microbio Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -267.99 -203.92 -370.06 -59.56 -31.62

ROCO:4128 vs KHC, GIS: EBITDA Comparison

For the Packaged Foods subindustry, Microbio Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbio Co EV-to-EBITDA vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Microbio Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Microbio Co's EV-to-EBITDA falls into.


ROCO:4128
56GF Score
Microbio Co Ltd ROCO:4128
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Microbio Co's EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Microbio Co's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2025, Microbio Co's EBITDA was NT$-665 Mil.

Microbio Co's EBITDA for the quarter that ended in Dec. 2025 is calculated as

Microbio Co's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2025, Microbio Co's EBITDA was NT$-32 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-665 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of NT$-665 Mil mean?
Microbio Co (ROCO:4128) has a EBITDA of NT$-665 Mil as of Dec. 2025. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Microbio Co.
Is Microbio Co's EBITDA too high?
Microbio Co's current EBITDA is NT$-665 Mil. Overall, Microbio Co has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Microbio Co's EBITDA compare to KHC and GIS?
Microbio Co's EBITDA of NT$-665 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Consumer Packaged Goods company?
A good EBITDA depends on the Consumer Packaged Goods industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Microbio Co. Microbio Co's current EBITDA is NT$-665 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbio Co stock overvalued right now?
Based on GuruFocus' analysis, Microbio Co (ROCO:4128) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$45.77, compared to a current price of NT$15.85 — trading 65.4% below its estimated fair value. The current EBITDA is NT$-665 Mil. Microbio Co's overall GF Score™ is 56/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Microbio Co (ROCO:4128), the current EBITDA is NT$-665 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbio Co (ROCO:4128) Overvalued in 2026?

Based on GuruFocus' analysis, Microbio Co stock appears to be undervalued. The current stock price of NT$15.85 is trading 65.4% below its estimated GF Value™ of NT$45.77. GuruFocus considers Microbio Co to be Significantly Undervalued.

Key valuation signals for ROCO:4128:

  • EBITDA: NT$-665 Mil
  • GF Value™: NT$45.77 vs. price of NT$15.85 (65.4% below fair value)
  • GF Score™: 56/100 with 1 warning sign

No single metric tells the full story. See the ROCO:4128 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Microbio Co Business Description

Address Yuanqu Street, No. 3, 18th Floor - 1, Sanchong Village, Nangang District, Taipei, TWN
Microbio Co Ltd is engaged in the research and development, manufacturing, and trading of biotech drugs and dietary supplements. Its drug portfolio includes MS-20, a mixture of soybean fermentation metabolites, which improves fatigue and loss of appetite in cancer patients undergoing chemotherapy. In addition, the company also offers Lee Herb series of herbal essence drinks, Tien Chun Bao oral solutions, Herbiron oral solutions for iron deficiency, and other pharmaceutical and organic products. The company generates revenue from biotech drug research and development and the sale of dietary supplements. The majority of its revenue is generated from the sale of its dietary supplements.
56GF Score

Get the complete analysis for ROCO:4128

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.85
Price
NT$45.77
GF Value